GlassScriptPhysician profile
Jan M Barrios
NPI 1164538138
$11,553.14
in general payments reported to CMS, 2019-2025
34 companies · $1,411 in 2025
The $1,411 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,540 · 2020: $1,287 · 2021: $2,002 · 2022: $2,108 · 2023: $1,599 · 2024: $1,607 · 2025: $1,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,616.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,948.97 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $2,927.85 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Janssen Biotech, INC. | $1,081.05 | 2019-2025 | Stelara, Simponi Aria, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $1,019.64 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Redhill Biopharma INC. | $532.32 | 2020-2025 | Talicia, Aemcolo |
| Madrigal Pharmaceuticals | $416.00 | 2024-2025 | Rezdiffra, Resmetirom |
| Celgene Corporation | $401.75 | 2021-2023 | Zeposia |
| Mauna Kea Technologies, INC. | $341.52 | 2022-2025 | |
| Gilead Sciences, INC. | $259.95 | 2019-2024 | |
| Braintree Laboratories, INC. | $200.84 | 2019-2025 | Sutab, Suflave |
| Nestle Healthcare Nutrition INC. | $162.55 | 2020-2022 | |
| Boston Scientific Corporation | $142.57 | 2023-2025 | Axonics, Compliance Endokit, Cre Pro |
| Pfizer INC. | $138.10 | 2022-2025 | |
| Intercept Pharmaceuticals, INC. | $126.79 | 2020-2024 | Ocaliva |
| Allergan, INC. | $123.13 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $93.20 | 2019 | |
| Ironwood Pharmaceuticals, INC | $89.11 | 2019-2021 | |
| Vivus LLC | $70.83 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $65.36 | 2025 | Voquezna |
| Ipsen Biopharmaceuticals, INC | $47.31 | 2024 | Iqirvo |
| Axonics, INC. | $46.50 | 2023-2024 | Axonics |
| Ardelyx, INC. | $46.49 | 2022 | |
| Alfasigma USA, INC. | $38.16 | 2020 | |
| Daiichi Sankyo INC. | $31.65 | 2020 | |
| Shire North American Group INC | $31.26 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.22 | 2025 | Dupixent |
| Biocon Biologics INC | $24.72 | 2024 | Hulio |
| Alnylam Pharmaceuticals INC. | $21.01 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.71 | 2019 | |
| Shionogi INC | $18.37 | 2019 | |
| Lilly USA, LLC | $17.67 | 2025 | Omvoh |
| E.R. Squibb & Sons, L.L.C. | $16.30 | 2022 | |
| Merck Sharp & Dohme LLC | $13.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Barrios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.